Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04660344 |
|---|---|
| Brief Title: | A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy (IMvigor011) |
| First Submitted : | December 1, 2020 |
| First Submitted that Met QC Criteria : | December 7, 2020 |
| First Posted : | December 9, 2020 |
| Last Update Submitted that Met QC Criteria : | April 18, 2024 |
| Last Update Posted : | April 22, 2024 |